Torren Management’s Inhibrx INBX Stock Holding History

Torren Management’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.4K	Hold	110	–	–	0.01%	208
2026 Q1	$7.39K	Hold	110	–	–	﹤0.01%	242
2025 Q4	$8.69K	Buy	+110	New	+$7.5K	﹤0.01%	796

Other funds holding INBX

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

HSA

Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

EWM

Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

Torren Management's INBX Position: Q2 2026 in Review

Torren Management held its Inhibrx (INBX) position steady in Q2 2026 at 110 shares worth $10.4K. The position accounts for 0.01% of the portfolio, ranked #208.

Torren Management first reported a position in INBX in Q4 2025 and has held it in 3 quarters since. 46 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

Torren Management held 110 shares of Inhibrx worth $10.4K as of Q2 2026.
Torren Management left its Inhibrx share count unchanged in Q2 2026.
Inhibrx made up 0.01% of Torren Management's portfolio in Q2 2026, its #208 holding.
Torren Management first reported a position in Inhibrx in Q4 2025 and has held it in 3 quarters since.
46 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Torren Management's 13F filing for Q2 2026, filed 10 Jul 2026.